Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in human neocortex slices: Involvement of 5-HT(2C) and 5-HT(1A) receptors

British Journal of Pharmacology

Volumn 130, Issue 8, 2000, Pages 1853-1858

  Maura, Guido ^a   Marcoli, Manuela ^a   Pepicelli, Olimpia ^a   Rosu, Christian ^a   Viola, Concetta ^b   Raiteri, Maurizio ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

5 HT(1A) receptor; 5 HT(2C) receptor; 5 hydroxytryptamine glutamate interaction; Cyclic GMP; Human neocortex; Nitric oxide; NMDA receptor

Indexed keywords

1 (1 METHYL 5 INDOLYL) 3 (3 PYRIDYL)UREA; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; 4 IODO 2,5 DIMETHOXYAMPHETAMINE; ALPHA (2,3 DIMETHOXYPHENYL) 1 [2 (4 FLUOROPHENYL)ETHYL] 4 PIPERIDINEMETHANOL; CYCLIC GMP; GUANYLATE CYCLASE INHIBITOR; KETANSERIN; MESULERGINE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; N(G) NITROARGININE; NITRIC OXIDE; RAUWOLSCINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN ANTAGONIST; TRAZODONE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NEOCORTEX; PRIORITY JOURNAL;

EID: 0033846737     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703510     Document Type: Article

References (51)

1. 2 receptor regulation of extracellular GABA levels in the prefrontal cortex
2. Localization of the 5-hydroxytryptamine(2C) receptor protein in human and rat brain using specific antisera
3. A review of central 5-HT receptors and their function
4. 2 receptor subtypes: A family re-united?
5. Current advances and trends in the treatment of depression
6. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding
7. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum
8. Antidepressant properties of trazodone
9. 2+ levels in neuronal culture
10. Binding of antidepressants to human brain receptors: Focus on newer generation compounds
11. Effect of cinanserin on the release of glutamate from rat cerebellar slices
12. Potassium-stimulated release of nitric oxide from cerebellar slices
13. NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway
14. In vivo studies of the cerebral glutamate receptor/NO/cGMP pathway
15. Electrophysiological, biochemical, neurohormonal and behavioural studies with WAY-100635, a potent, selective and silent 5-HT(1A) receptor antagonist
16. N-(1-methyl-5-indolyl)-N'-(3-pyridyl)urea hydrochloride: The first selective 5-HT(1C) receptor antagonist
17. Interactions of trazodone with serotonin neurons and receptors
18. Effects of trazodone on serotonin in the brain and platelets of the rat
19. Excitatory amino acid receptors and guanosine 3',5'-cyclic monophosphate in incubated slices of immature and adult rat cerebellum
20. Supersensitivity to the cyclic GMP response to glutamate during cerebellar maturation
21. Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders
22. Identification of 5-hydroxytryptamine receptors positive coupled to adenylyl cyclase in rat cultured astrocytes
23. International Union of Pharmacology classification of receptors for 5-hydroxytrypamine (Serotonin)
24. Evidence for a role of 5-HT(1C) receptors in the antiserotonergic properties of some antidepressant drugs
25. Effects of RO 60 0175, a 5-HT(2C) receptor agonist, in three animal models of anxiety
26. SB-242084, a selective and brain penetrant 5-HT(2C) receptor antagonist
27. Recent pharmacologic advances in antidepressants therapy
28. The role of noradrenaline in depression: A review
29. Behavioral studies of serotonin receptor agonists as antidepressant drugs
30. Pharmacological diversity between native human 5-HT(1B) and 5-HT(1D) receptors sited on different neurons and involved in different functions
31. Serotonin inhibition of the NMDA receptor/nitric oxide/cyclic GMP pathway in rat cerebellum: Involvement of 5-hydroxy-tryptamine(2C) receptors
32. 5-HT(2C) receptor agonists: Pharmacological characteristics and therapeutic potential
33. Serotonin 5-HT(1D) 5-HT(1A) receptors respectively mediate inhibition of glutamate release and inhibition of cyclic GMP production in rat cerebellum in vitro
34. Low nanomolar serotonin inhibits the glutamate receptor/nitric oxide/cyclic GMP pathway in slices from adult rat cerebellum
35. Glutamate release in human cerebral cortex and its modulation by 5-hydroxytryptamine acting at h5-HT(1D) receptors
36. Actions of 5-HT on human neocortical neurones in vitro
37. Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors
38. Neurotransmitter receptor and transporter binding profile of antidepressant and their metabolites
39. 2 receptor family mRNAs: Comparison between 5-HT(2A) and 5-HT(2C) receptors
40. 1-like receptors on glutamatergic terminals inhibits N-methyl-D-aspartate-induced cyclic GMP production in rat cerebellar slices
41. 1 receptors modulating transmitter release in rat cerebellum
42. Electrophysiological examination of the effects of sustained flibanserin administration on serotonin receptors in rat brain
43. Activities of novel aryloxyalkylimidazolines on rat 5-HT(2A) and 5-HT(2C) receptors
44. Selective inhibition of serotonin uptake by trazodone, a new antidepressant agent
45. 3H]5-carboxamido-tryptamine
46. Anxiolytic antidepressant augmentation
47. Pharmacological studies on YM99, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT(2A) receptor antagonistic activity
48. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
49. Extracellular cGMP in the hippocampus of freely moving rats as an index of nitric oxide (NO) synthase activity
50. Pharmacologic characterization of the human 5-hydroxytrypamine(2B) receptor: Evidence for species differences
51. Excitatory amino acid signal transduction in the hippocampus: Role of noradrenergic afferents and nitric oxide in cGMP increases in vivo